Guy Hewlett

This inventor holds 9 USPTO granted patents, plus 6 CIPO patents and 4 EPO patents. Top assignees: Aicuris Gmbh + Co. Kg., Bayer Schering Pharma Ag, Aic246 Ag & Co. Kg. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guy Hewlett. Retrieved from https://idiyas.com/inventor/guy-hewlett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9

% Patents Active = 77.8

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 4

Average Co-Inventor Count = 13.7

ph-index = 4

Forward Citations = 41(Granted Patents)

Location History:

Haan, DE (2013)
Wuppertal, DE (2007 - 2023)

Company Filing History:

4 out of 53

Aicuris Gmbh + Co. Kg.

patents

2 out of 192

Bayer Schering Pharma Ag

Aicuris Anti-Infective Cures Gmbh

patents

5. 1 out of 77

Bayer Healthcare Aktiengesellschaft

patents

Years Active: 2007-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49698 - Substituted dihydroquinazolines (2023-10-17),

2. RE46791 - Substituted dihydroquinazolines (2018-04-16),

3. 8513255 - Substituted dihydroquinazolines (2013-08-20),

4. 8343981 - Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents (2013-01-01),

5. 8314113 - Substituted dihydroquinazolines II (2012-11-20),

6. 7960387 - 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses (2011-06-14),

7. 7767704 - Antiviral 4-aminocarbonylamino-substituted imidazole compounds (2010-08-03),

8. 7709491 - Substituted quinazolines as antiviral agents, especially against cytomegaloviruses (2010-05-04),

9. 7196086 - Substituted dihydroquinazolines (2007-03-27),

Title: Guy Hewlett: Innovator in Medicinal Chemistry

Introduction

Guy Hewlett is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral agents. With a total of 9 patents to his name, Hewlett's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest innovations are patents related to substituted dihydroquinazolines. These inventions focus on the preparation and application of these compounds for creating medicaments aimed at treating and preventing diseases, especially as antiviral agents against cytomegaloviruses. His research in this area highlights the importance of developing effective treatments for viral infections.

Career Highlights

Throughout his career, Guy Hewlett has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Aicuris GmbH & Co. KG and Bayer Schering Pharma AG. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Hewlett has collaborated with several professionals in his field, including Holger Zimmermann and Kerstin Henninger. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Guy Hewlett's contributions to medicinal chemistry and his innovative patents demonstrate his commitment to improving healthcare through scientific advancements. His work continues to pave the way for new treatments in the fight against viral diseases.

Profile summary based on public USPTO records.